Literature DB >> 20163831

Influence of cellular and plasma procoagulant activity on the fibrin network.

Alisa S Wolberg1, Maria M Aleman.   

Abstract

At the nexus of cellular and plasma procoagulant activities lies fibrin, which is necessary to provide a clot's structural support. Abnormalities in fibrin network formation or function can result in either bleeding or thrombotic complications. Understanding relationships between procoagulant activity and normal fibrin formation, as well as pathophysiologic mechanisms leading to abnormal fibrin deposition, is essential for the continued development of hemostatic and antithrombotic therapies. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20163831      PMCID: PMC2839015          DOI: 10.1016/j.thromres.2010.01.033

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  26 in total

1.  Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.

Authors:  J P Collet; D Park; C Lesty; J Soria; C Soria; G Montalescot; J W Weisel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

2.  Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition.

Authors:  C J Glover; L V McIntire; C H Brown; E A Natelson
Journal:  J Lab Clin Med       Date:  1975-10

3.  Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides.

Authors:  J W Weisel
Journal:  Biophys J       Date:  1986-12       Impact factor: 4.033

4.  IL-4 inhibits LPS-, IL-1 beta- and TNF alpha-induced expression of tissue factor in endothelial cells and monocytes.

Authors:  J M Herbert; P Savi; M C Laplace; A Lale
Journal:  FEBS Lett       Date:  1992-09-21       Impact factor: 4.124

5.  Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives.

Authors:  Anetta Undas; Krystyna Zawilska; Mariola Ciesla-Dul; Agata Lehmann-Kopydłowska; Agnieszka Skubiszak; Katarzyna Ciepłuch; Wiesława Tracz
Journal:  Blood       Date:  2009-08-18       Impact factor: 22.113

6.  The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX.

Authors:  S He; M Blombäck; G Jacobsson Ekman; U Hedner
Journal:  J Thromb Haemost       Date:  2003-06       Impact factor: 5.824

7.  High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.

Authors:  Timothy A Morris; James J Marsh; Peter G Chiles; Marisa M Magaña; Ni-Cheng Liang; Xavier Soler; Daniel J Desantis; Debby Ngo; Virgil L Woods
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

8.  Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface.

Authors:  Robert A Campbell; Katherine A Overmyer; C Robert Bagnell; Alisa S Wolberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-10-30       Impact factor: 8.311

9.  Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress.

Authors:  Anetta Undas; Konstanty Szułdrzynski; Ewa Stepien; Jarosław Zalewski; Jacek Godlewski; Wiesława Tracz; Mieczysław Pasowicz; Krzysztof Zmudka
Journal:  Atherosclerosis       Date:  2007-07-20       Impact factor: 5.162

10.  Effect of temperature, pH and ionic strength and composition on fibrin network structure and its development.

Authors:  C H Nair; G A Shah; D P Dhall
Journal:  Thromb Res       Date:  1986-06-15       Impact factor: 3.944

View more
  5 in total

1.  Flow profoundly influences fibrin network structure: implications for fibrin formation and clot stability in haemostasis.

Authors:  Robert A Campbell; Maria Aleman; Laura D Gray; Michael R Falvo; Alisa S Wolberg
Journal:  Thromb Haemost       Date:  2010-09-30       Impact factor: 5.249

2.  Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin.

Authors:  Daria Zamolodchikov; Sidney Strickland
Journal:  Blood       Date:  2012-01-11       Impact factor: 22.113

3.  Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death.

Authors:  Florian Posch; Stefanie Hofer; Johannes Thaler; Lena Hell; Oliver Königsbrügge; Ella Grilz; Lisa-Marie Mauracher; Johanna Gebhart; Christine Marosi; Bernd Jilma; Ingrid Pabinger; Cihan Ay
Journal:  Transl Res       Date:  2019-08-29       Impact factor: 7.012

Review 4.  Comprehensive overview of COVID-19-related respiratory failure: focus on cellular interactions.

Authors:  Fahimeh Zamani Rarani; Mohammad Zamani Rarani; Michael R Hamblin; Bahman Rashidi; Seyed Mohammad Reza Hashemian; Hamed Mirzaei
Journal:  Cell Mol Biol Lett       Date:  2022-07-30       Impact factor: 8.702

5.  MetAmyl: a METa-predictor for AMYLoid proteins.

Authors:  Mathieu Emily; Anthony Talvas; Christian Delamarche
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.